INS and pancreatic neoplasm: However, the International Pancreatic Cancer Case-Control Consortium [59] assessed the effect of insulin on PC risk in patients with T2DM as unclear; a short period of insulin use (<5 years) significantly increased PC risk, while a longer period (>15 years) did not.